Hydrea
Hydrea (Hydroxyurea 500 mg) — BMS ribonucleotide reductase inhibitor for chronic myeloid leukaemia, polycythaemia vera, essential thrombocythaemia, sickle cell disease.
✓ Verificat medical de Morgan Ellis — Cercetător farmaceutic · 8 ani de experiență · Ultima recenzie: mai 2026
Răspuns rapid
Hydrea — Hydroxyurea 500 mg (Bristol Myers Squibb). Ribonucleotide reductase inhibitor for chronic myeloid leukaemia (older first-line, now second-line after BCR-ABL TKIs), polycythaemia vera, essential thrombocythaemia, sickle cell disease, refractory cytoreduction.
Ce beneficii oferă MedsBase:
- producător certificat WHO-GMP
- Ambalaj discret în plic simplu
- Livrare în toată lumea
- Evaluat de peste 1.400 de clienți (citește recenziile)
📦 Garanția de retransmitere: dacă comanda dvs. nu a ajuns în 20 de zile lucrătoare de la expediere, o retransmitem fără costuri suplimentare. Citește politica.
De ce să comanzi de la MedsBase
Hydrea ships from a WHO-GMP certified manufacturer in plain packaging, billed through a regulated payment processor (the statement descriptor reads a regulated card-payment processor — never MedsBase or any medication name). Every order carries our 20-business-day Reshipment Assurance.
⚠️ Specialist-supervised cancer therapy — this medication is started, monitored, and stopped by an oncologist or haematologist. Dosing depends on tumour type, stage, body surface area, organ function, and concomitant therapy. Self-treatment is not appropriate; the information below is educational and supports informed conversations with your specialist.
Cumulative myelosuppression — weekly FBC initially. Cutaneous side effects: leg ulcers (especially ankles), nail/skin pigmentation, secondary skin cancers (squamous cell). Avoid in pregnancy (teratogenic) and breastfeeding.
Întrebări frecvente
When is this used?
Ribonucleotide reductase inhibitor for chronic myeloid leukaemia (older first-line, now second-line after BCR-ABL TKIs), polycythaemia vera, essential thrombocythaemia, sickle cell disease, refractory cytoreduction. Specific protocols are oncologist-determined.
Side effects?
Class-typical: myelosuppression, nausea, alopecia, mucositis, fatigue. Specific toxicities depend on the drug — see safety boxes above.
Interacțiuni medicamentoase?
Cancer chemotherapy has multiple critical interactions. Always disclose all medications including herbals and supplements. Anticoagulants, anticonvulsants, antibiotics, antifungals, and antivirals all need review.
Sarcină?
Cytotoxic chemotherapy is teratogenic. Effective contraception during and for 6 months after for both partners.
Monitoring?
Specialist-determined — typically FBC, renal/liver function, electrolytes before each cycle. Drug-specific tests (echocardiogram for anthracyclines, audiometry for cisplatin, etc.).
Ce fac dacă uit o doză?
Oral cytotoxics: skip the missed dose, do not double up, contact your oncology team. IV: dosing is strictly scheduled — discuss any delay or missed cycle with the specialist.
Storage?
Oral cytotoxics: at room temperature, away from children, in original blister. Hand washing after handling tablets. Pregnant household members should not handle broken tablets.
Vaccines?
Live vaccines are contraindicated during chemotherapy. Inactivated vaccines (annual influenza, pneumococcal) are recommended. Coordinate with oncology for timing.
Long-term complications?
Class-dependent: secondary malignancy, infertility, cardiotoxicity, neuropathy. Discuss with oncology — fertility preservation may be relevant before starting.
When is treatment finished?
Determined by tumour response, treatment intent (curative vs palliative), and toxicity. Imaging and clinical assessment guide ongoing therapy.
Other Cancer Medications
- Xeloda — capecitabine 500 mg — oral 5-FU prodrug for breast/colorectal/gastric cancers
- Altraz — anastrozole 1 mg — aromatase inhibitor for post-menopausal breast cancer
- Xbira — abiraterone 250 mg — CYP17 inhibitor for metastatic prostate cancer
- Zoldria — zoledronic acid IV — for bone metastases and hypercalcaemia
- Actorise — darbepoetin alfa — for chemotherapy-induced anaemia
More options in Anti Cancer Medication
Clasificate în funcție de volumul recent de comenzi MedsBase — ce aleg alți clienți în această categorie.
| Concentrație | 500 mg |
|---|---|
| Cantitate | 30 Capsule/s, 60 Capsule/s, 90 Capsule/s |
| Formă farmaceutică | Capsule |
| Producător | Sarabhai Chemicals |
| Indicație | Resistant chronic myeloid leukemia |
| Brand generic | Hydroxyurea |
Hydrea
Întrebări și răspunsuri
Hydrea
Produse similare
Recenzii
Nu există recenzii încă